E3 PreliminaryWeak / uncertainPEM not requiredReview-NarrativePeer-reviewedMachine draft
Standard · 3 min
[Fibromyalgia. A critical review].
Cathébras, P, Lauwers, A, Rousset, H · Annales de medecine interne · 1998
Quick Summary
Fibromyalgia is a chronic pain condition that affects about 2% of the general population, with symptoms including widespread pain, fatigue, and sleep problems. This review examines how fibromyalgia overlaps with other conditions like ME/CFS and depression, and discusses why current treatments like antidepressants and therapy have limited effectiveness. The authors suggest that fibromyalgia may develop through interconnected factors rather than a single cause.
Why It Matters
This paper is important for ME/CFS patients and researchers because it directly addresses the overlap and comorbidity between fibromyalgia and ME/CFS, highlighting diagnostic and etiological challenges shared between these syndromes. Understanding fibromyalgia's apparent multifactorial pathophysiology and treatment limitations may inform similar research directions for ME/CFS. The paper's critique of current diagnostic criteria emphasizes why distinguishing between overlapping functional somatic syndromes remains clinically crucial.
Observed Findings
Fibromyalgia prevalence is approximately 2% in the general population and up to 20% among rheumatology outpatients.
Fibromyalgia shows striking comorbidity with depression, anxiety, ME/CFS, and irritable bowel syndrome, which current diagnostic criteria cannot reliably distinguish.
Current pharmacological (antidepressants) and psychological (cognitive-behavioral therapy) treatments show little efficacy.
Stress response studies reveal subtle anomalies in fibromyalgia patients.
Prognosis is poor, particularly in specialized clinic populations with severe illness behaviors.
Inferred Conclusions
Fibromyalgia likely results from multiple interconnected etiological factors rather than a single cause, converging on a final common pathway of generalized hyperalgesia.
Psychiatric disorders may represent vulnerability and perpetuation factors rather than primary causes of fibromyalgia.
Muscle and sleep disturbance are not primary pathophysiological drivers of the syndrome.
Improvement in outcomes may occur outside specialized clinic settings where chronic sufferers develop severe abnormal illness behaviors.
Remaining Questions
What are the specific neurobiological mechanisms underlying generalized hyperalgesia in fibromyalgia?
What This Study Does Not Prove
This review does not establish the actual cause or primary mechanism of fibromyalgia, nor does it provide empirical evidence for the proposed 'final common pathway' model. The paper does not prove that fibromyalgia and ME/CFS are the same condition, only that they share diagnostic and comorbidity challenges. As a critical review rather than primary research, it cannot confirm the efficacy or inefficacy of specific treatments through clinical trial data.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
How can diagnostic criteria be refined to accurately distinguish fibromyalgia from ME/CFS, IBS, and psychiatric conditions while accounting for comorbidity?
Why are current pharmacological and psychological treatments so ineffective, and what alternative therapeutic approaches should be investigated?
How do illness behaviors and social factors influence fibromyalgia prognosis, and can addressing these improve outcomes?